Summit Therapeutics plc Stock Forecast
Summit Therapeutics plc stock price down 1.68% on Thursday
(Updated on Apr 18, 2024)
The Summit Therapeutics plc stock price fell by -1.68% on the last day (Thursday, 18th Apr 2024) from $3.57 to $3.51. During the last trading day the stock fluctuated 4.57% from a day low at $3.50 to a day high of $3.66. The price has been going up and down for this period, and there has been a -0.85% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -168 thousand shares and in total, 1 million shares were bought and sold for approximately $4.23 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.61% during the next 3 months and, with a 90% probability hold a price between $2.88 and $4.42 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
SMMT Signals & Forecast
There are mixed signals in the stock today. The Summit Therapeutics plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.71 and $4.05. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Monday, March 25, 2024, and so far it has risen 7.01%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Summit Therapeutics plc stock
Summit Therapeutics plc finds support from accumulated volume at $3.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.160 between high and low, or 4.57%. For the last week, the stock has had daily average volatility of 5.95%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (SMMT) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Summit Therapeutics plc to open at $3.56, and during the day (based on 14 day Average True Range), to move between $3.19 and $3.83, which gives a possible trading interval of +/-$0.321 (+/-9.15%) up or down from last closing price. If Summit Therapeutics plc takes out the full calculated possible swing range there will be an estimated 18.30% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.37 (3.99%) than the resistance at $3.74 (6.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Summit Therapeutics plc stock A Buy?
Summit Therapeutics plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -4.043 Sell Candidate Unchanged
Predicted Opening Price for Summit Therapeutics plc of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $3.56 ( 1.33%) | $3.51 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for SMMT
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.72 | 5.89 % | |
| R2 | 3.66 | 4.15 % | ||
| R1 | 3.62 | 3.07 % | ||
| Current price: | 3.51 | |||
| Support | S1 | 3.50 | -0.412 % | |
| S2 | 3.46 | -1.49 % | ||
| S3 | 3.40 | -3.23 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.88 | 10.54 % | |
| R2 | 3.77 | 7.41 % | ||
| R1 | 3.74 | 6.55 % | ||
| Current price | 3.51 | |||
| Support | S1 | 3.37 | -3.99% | |
| S2 | 3.28 | -6.55% | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Summit Therapeutics plc Stock.
